Back to mobile site

TD Cowen Reiterates Buy Rating on Twist Bioscience (TWST)

November 18, 2024 2:08 PM EST Send to a Friend
TD Cowen analyst Steven Mah reiterated a Buy rating and $58.00 price target on Twist Bioscience (NASDAQ: TWST).The analyst commented ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login